Cingulate Inc. Insider Trading
CING
Insiders bought 657K on the open market and sold nothing.
Get an email when CING's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13 | Thomas Jeffrey Hargroves Director | Bought | 97,276 | $5.04 | 490K | 50665% | Form 4 |
| Feb 6 | Peter J. Werth Director | Bought | 19,455 | $5.04 | 98K | 20% | Form 4 |
| Feb 6 | Jennifer L. Callahan SVP and CFO | Bought | 4,864 | $5.04 | 25K | 2494% | Form 4 |
| Feb 6 | Shane J. Schaffer Chief Executive Officer | Bought | 6,809 | $5.04 | 34K | 192% | Form 4 |
| Feb 6 | Matthew Brams EVP and Chief Medical Officer | Bought | 1,946 | $5.04 | 10K | 72% | Form 4 |
- Feb 13Thomas Jeffrey HargrovesDirector · bought 97,276 at $5.04490K50665% of stake
- Feb 6Peter J. WerthDirector · bought 19,455 at $5.0498K20% of stake
- Feb 6Jennifer L. CallahanSVP and CFO · bought 4,864 at $5.0425K2494% of stake
- Feb 6Shane J. SchafferChief Executive Officer · bought 6,809 at $5.0434K192% of stake
- Feb 6Matthew BramsEVP and Chief Medical Officer · bought 1,946 at $5.0410K72% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with CING
Spot a number that looks wrong? Check it in CING's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CING
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.